ZIVOZivo Bioscience, Inc.vs its industry peers
A metric-by-metric comparison of Zivo Bioscience, Inc. against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ZIVOEsta | $5M#3 | — | — | 31.3x#1 | 468.6%#1 | -72.1%#2 | -8498.9%#1 | — | — | — | 0.0%#1 | — |
| SLXN | $8M#1 | 0.3x#1 | 26.8x#2 | — | — | 27.9%#1 | — | -4093.5%#2 | — | — | — | — |
| PMCB | $6M#2 | — | 0.2x#1 | — | — | -163.4%#3 | — | -58.3%#1 | -40.0%#1 | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-08-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice